Service Users' Views and Experiences of Alcohol Relapse Prevention Treatment and Adherence: New Role for Pharmacists?

Ranjita Dhital; Rachel Coleman; Ed Day; Colin Drummond; Anne Lingford-Hughes; John Marsden; Tom Phillips; Julia Sinclair; John Strang; John Weinman; Cate Whittlesea; Kideshini Widyaratna; Kim Donoghue

doi:10.1093/alcalc/agac011

Service Users' Views and Experiences of Alcohol Relapse Prevention Treatment and Adherence: New Role for Pharmacists?

Ranjita Dhital^*, Rachel Coleman, Ed Day, Colin Drummond, Anne Lingford-Hughes, John Marsden, Tom Phillips, Julia Sinclair, John Strang, John Weinman, Cate Whittlesea, Kideshini Widyaratna, Kim Donoghue

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

66 Downloads (Pure)

Abstract

Aims: To understand service users' views and experiences of alcohol relapse prevention medication, views of a telephone behavioural modification intervention delivered by pharmacists and the use of Contingency Management (CM) to support acamprosate adherence following assisted alcohol withdrawal.

Methods: Four focus groups were conducted within four alcohol treatment and recovery groups across England (UK), with service users with lived experience of alcohol dependence (26 participants). Semi-structured topic guide was used to explore participants' views and experiences of alcohol relapse prevention medication, a telephone behavioural modification medication intervention delivered by pharmacists, and the use of CM to support acamprosate adherence. These were audio-recorded, transcribed verbatim and thematically analysed inductively and deductively.

Results: Four themes were identified: concerns about support and availability of alcohol relapse prevention medication; lack of knowledge and understanding about acamprosate treatment; positive perceptions of acamprosate adherence telephone support from pharmacists; and negative perceptions of CM to support acamprosate adherence. There were misunderstandings about acamprosate's mode of action and strong negative beliefs about CM. However, most were positive about pharmacists' new role to support acamprosate adherence.

Conclusion: This study highlighted challenges service users face to commence alcohol relapse prevention medication. It appears service users could benefit from a pharmacist-led telephone intervention to improve understanding about acamprosate medication, particularly, if delivered in an engaging and motivating way.

Original language	English
Pages (from-to)	602-608
Number of pages	7
Journal	Alcohol and Alcoholism
Volume	57
Issue number	5
Early online date	15 Mar 2022
DOIs	https://doi.org/10.1093/alcalc/agac011
Publication status	Published - Sept 2022

Bibliographical note

Publisher Copyright:
© 2022 The Author(s). Medical Council on Alcohol and Oxford University Press. All rights reserved.

ASJC Scopus subject areas

Medicine (miscellaneous)
Toxicology
Psychiatry and Mental health

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/alcalc/agac011Licence: Creative Commons: Attribution-NonCommercial (CC BY-NC)

DhitalR2022ServiceFinal published version, 328 KBLicence: Creative Commons: Attribution-NonCommercial (CC BY-NC)

Cite this

Dhital, R., Coleman, R., Day, E., Drummond, C., Lingford-Hughes, A., Marsden, J., Phillips, T., Sinclair, J., Strang, J., Weinman, J., Whittlesea, C., Widyaratna, K., & Donoghue, K. (2022). Service Users' Views and Experiences of Alcohol Relapse Prevention Treatment and Adherence: New Role for Pharmacists? Alcohol and Alcoholism, 57(5), 602-608. https://doi.org/10.1093/alcalc/agac011

@article{a684e668cad0401887ed2958483e3357,

title = "Service Users' Views and Experiences of Alcohol Relapse Prevention Treatment and Adherence: New Role for Pharmacists?",

abstract = "Aims: To understand service users' views and experiences of alcohol relapse prevention medication, views of a telephone behavioural modification intervention delivered by pharmacists and the use of Contingency Management (CM) to support acamprosate adherence following assisted alcohol withdrawal. Methods: Four focus groups were conducted within four alcohol treatment and recovery groups across England (UK), with service users with lived experience of alcohol dependence (26 participants). Semi-structured topic guide was used to explore participants' views and experiences of alcohol relapse prevention medication, a telephone behavioural modification medication intervention delivered by pharmacists, and the use of CM to support acamprosate adherence. These were audio-recorded, transcribed verbatim and thematically analysed inductively and deductively. Results: Four themes were identified: concerns about support and availability of alcohol relapse prevention medication; lack of knowledge and understanding about acamprosate treatment; positive perceptions of acamprosate adherence telephone support from pharmacists; and negative perceptions of CM to support acamprosate adherence. There were misunderstandings about acamprosate's mode of action and strong negative beliefs about CM. However, most were positive about pharmacists' new role to support acamprosate adherence. Conclusion: This study highlighted challenges service users face to commence alcohol relapse prevention medication. It appears service users could benefit from a pharmacist-led telephone intervention to improve understanding about acamprosate medication, particularly, if delivered in an engaging and motivating way.",

author = "Ranjita Dhital and Rachel Coleman and Ed Day and Colin Drummond and Anne Lingford-Hughes and John Marsden and Tom Phillips and Julia Sinclair and John Strang and John Weinman and Cate Whittlesea and Kideshini Widyaratna and Kim Donoghue",

year = "2022",

month = sep,

doi = "10.1093/alcalc/agac011",

language = "English",

volume = "57",

pages = "602--608",

journal = "Alcohol and Alcoholism",

issn = "0735-0414",

publisher = "Oxford University Press",

number = "5",

}

Dhital, R, Coleman, R, Day, E, Drummond, C, Lingford-Hughes, A, Marsden, J, Phillips, T, Sinclair, J, Strang, J, Weinman, J, Whittlesea, C, Widyaratna, K & Donoghue, K 2022, 'Service Users' Views and Experiences of Alcohol Relapse Prevention Treatment and Adherence: New Role for Pharmacists?', Alcohol and Alcoholism, vol. 57, no. 5, pp. 602-608. https://doi.org/10.1093/alcalc/agac011

TY - JOUR

T1 - Service Users' Views and Experiences of Alcohol Relapse Prevention Treatment and Adherence

T2 - New Role for Pharmacists?

AU - Dhital, Ranjita

AU - Coleman, Rachel

AU - Day, Ed

AU - Drummond, Colin

AU - Lingford-Hughes, Anne

AU - Marsden, John

AU - Phillips, Tom

AU - Sinclair, Julia

AU - Strang, John

AU - Weinman, John

AU - Whittlesea, Cate

AU - Widyaratna, Kideshini

AU - Donoghue, Kim

PY - 2022/9

Y1 - 2022/9

N2 - Aims: To understand service users' views and experiences of alcohol relapse prevention medication, views of a telephone behavioural modification intervention delivered by pharmacists and the use of Contingency Management (CM) to support acamprosate adherence following assisted alcohol withdrawal. Methods: Four focus groups were conducted within four alcohol treatment and recovery groups across England (UK), with service users with lived experience of alcohol dependence (26 participants). Semi-structured topic guide was used to explore participants' views and experiences of alcohol relapse prevention medication, a telephone behavioural modification medication intervention delivered by pharmacists, and the use of CM to support acamprosate adherence. These were audio-recorded, transcribed verbatim and thematically analysed inductively and deductively. Results: Four themes were identified: concerns about support and availability of alcohol relapse prevention medication; lack of knowledge and understanding about acamprosate treatment; positive perceptions of acamprosate adherence telephone support from pharmacists; and negative perceptions of CM to support acamprosate adherence. There were misunderstandings about acamprosate's mode of action and strong negative beliefs about CM. However, most were positive about pharmacists' new role to support acamprosate adherence. Conclusion: This study highlighted challenges service users face to commence alcohol relapse prevention medication. It appears service users could benefit from a pharmacist-led telephone intervention to improve understanding about acamprosate medication, particularly, if delivered in an engaging and motivating way.

AB - Aims: To understand service users' views and experiences of alcohol relapse prevention medication, views of a telephone behavioural modification intervention delivered by pharmacists and the use of Contingency Management (CM) to support acamprosate adherence following assisted alcohol withdrawal. Methods: Four focus groups were conducted within four alcohol treatment and recovery groups across England (UK), with service users with lived experience of alcohol dependence (26 participants). Semi-structured topic guide was used to explore participants' views and experiences of alcohol relapse prevention medication, a telephone behavioural modification medication intervention delivered by pharmacists, and the use of CM to support acamprosate adherence. These were audio-recorded, transcribed verbatim and thematically analysed inductively and deductively. Results: Four themes were identified: concerns about support and availability of alcohol relapse prevention medication; lack of knowledge and understanding about acamprosate treatment; positive perceptions of acamprosate adherence telephone support from pharmacists; and negative perceptions of CM to support acamprosate adherence. There were misunderstandings about acamprosate's mode of action and strong negative beliefs about CM. However, most were positive about pharmacists' new role to support acamprosate adherence. Conclusion: This study highlighted challenges service users face to commence alcohol relapse prevention medication. It appears service users could benefit from a pharmacist-led telephone intervention to improve understanding about acamprosate medication, particularly, if delivered in an engaging and motivating way.

UR - http://www.scopus.com/inward/record.url?scp=85152942342&partnerID=8YFLogxK

U2 - 10.1093/alcalc/agac011

DO - 10.1093/alcalc/agac011

M3 - Article

C2 - 35292814

AN - SCOPUS:85152942342

SN - 0735-0414

VL - 57

SP - 602

EP - 608

JO - Alcohol and Alcoholism

JF - Alcohol and Alcoholism

IS - 5

ER -

Service Users' Views and Experiences of Alcohol Relapse Prevention Treatment and Adherence: New Role for Pharmacists?

Abstract

Bibliographical note

ASJC Scopus subject areas

UN SDGs

Access to Document

Fingerprint

Cite this